A world leader in the field of in vitro diagnostics for more than 55 years, bioMérieux is present in 45 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software and services) that determine the origin of a disease to improve the health of patients. World leader in microbiology, specialized in immunoassays and leading pioneer in the syndromic molecular approach, the Company is committed worldwide on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis and respiratory infections.